Precare conceive tablets

Rx only

Description

Each diamond shaped, film coated yellow tablet contains:

Vitamin C (as Ester-C ) * ...........................................................60 mg 

Calcium (as Calcium Carbonate)................................................200 mg 

Iron (as Ferrous Fumarate and Carbonyl Iron).............................30 mg 

Vitamin E (as dl-Alpha-Tocopheryl Acetate)................................30 IU 

Thiamine (as Thiamine Mononitrate)..............................................3 mg 

Riboflavin (Riboflavin, USP)......................................................3.4 mg 

Niacin (as Niacinamide, USP)....................................................20 mg 

Pyridoxine (as Pyridoxine HCl, USP).........................................50 mg 

Folic Acid, USP..........................................................................1 mg 

Magnesium (as Magnesium Oxide)..........................................100 mg 

Cyanocobalamin.....................................................................12 mcg

Zinc (as Zinc Oxide).................................................................15 mg 

Copper (as Cupric Oxide)..........................................................2 mg 

Inactive Ingredients:   Cellulose polymers, flow agents, pigment, natural wax, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, lactose and other ingredients.

*Ester-C is a patented pharmaceutical grade material consisting of calcium ascorbate and calcium threonate.

Ester-C is a licensed trademark of Zila Nutraceuticals, Inc.

INDICATIONS

PreCare Conceive tablets are indicated to provide vitamin and mineral supplementation which is useful to improve nutritional status prior to conception and throughout pregnancy.

Contraindications

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Warnings

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B 12 is deficient.

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Precautions

Folic acid in doses above 1.0 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.

PEDIATRIC USE

Safety and effectiveness in pediatric patients has not been established.

GERIATRIC USE

Clinical studies on this product have not been performed to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for elderly patients should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Adverse Reactions

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Dosage and Administration

Usual dosage is one tablet daily, or as prescribed by a physician.

How Supplied

PreCare Conceive tablets for oral administration are supplied as diamond shaped, film coated yellow tablets, debossed "Ther-Rx" on one side and "014" on the other side in child-resistant, unit dose packages of 100 tablets (10 × 10 Unit Dose Packs) (NDC 64011-014-11).

Store at controlled room temperature 15°-30°C (59°-86°F).

P3867 01/02

Drug Delivery Technology Provided

and Product Manufactured by

KV Pharmaceutical Co.

for Ther-Rx Corporation

St. Louis, MO 63045

U.S. Patents Nos. 4,822,816, 5,070,085 and 5,494,681

Other U.S. Patents Pending

PRODUCT PHOTO(S):

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug's identity should be verified by chemical analysis.
images/pills/p05334d6.jpg
Hide
(web3)